Bystander Fatigue and CPR Quality Using Continuous Compressions Versus 30:2 Compressions to Ventilation

NCT01397656 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2018-11-15

Study results available
· View outcomes & findings →

Summary

STUDY OBJECTIVES The overall goal of this study is to compare bystander fatigue and CPR quality after 5 minutes of continuous chest compressions versus the 2005 30:2 chest compression to ventilation Resuscitation Guidelines, in a population aged 55 or greater.

More specifically, the investigators will compare each CPR ratio with regard to:

1. The achieved frequency and depth of chest compressions, and
2. Participant rating of their perceived level of exertion.

STUDY HYPOTHESIS

In a population aged 55 or greater, the new CPR recommendations will lead to:

1. less frequent and shallower chest compressions over the 5-minute study period; and
2. higher rating of perceived level of exertion when compared to the 2005 30:2 CPR ratio.

Conditions

  • Cardiac Arrest

Interventions

PROCEDURE

CPR using 30:2 ratio

Participants will begin performing CPR using a ratio of 30 compressions to 2 ventilations. Participants will then cross over to the other intervention and use continuous compressions.

PROCEDURE

CPR using continuous compressions

Participants will begin performing CPR using continuous chest compressions. Participants will then cross-over to the other intervention arm and perform CPR using a ratio of 30 compressions to 2 ventilations.

Sponsors & Collaborators

  • Ottawa Hospital Research Institute

    lead OTHER

Principal Investigators

  • Christian Vaillancourt, MD, MSc · Ottawa Hospital Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2011-08-31
Completion
2011-09-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01397656 on ClinicalTrials.gov